<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
----------
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULE 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2(b)
(Amendment No. __)(1)
Shaman Pharmaceuticals Inc.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common
- --------------------------------------------------------------------------------
(Title of Class of Securities)
819319500
- --------------------------------------------------------------------------------
(CUSIP Number)
- --------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which
this Schedule is filed:
|X| Rule 13d-1 (b)
|_| Rule 13d-1 (c)
|_| Rule 13d-1 (d)
- ----------
(1) The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
Page 1 of 5
<PAGE>
CUSIP No. 819310500 SCHEDULE 13G Page 2 of 5 Pages
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Weiss, Peck & Greer, L.L.C.
13-2649199
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |_|
(b) |X|
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
-0-
--------------------------------------------------------------
NUMBER OF 6 SHARED VOTING POWER
SHARES
BENEFICIALLY 190,000
OWNED BY --------------------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING
PERSON -0-
WITH --------------------------------------------------------------
8 SHARED DISPOSITIVE POWER
190,000
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
190,000
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES*
|X|
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.71%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
BD, IA
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
Cusip No. 819319500 Page 3 of 5
Item 1(a). Name of Issuer: Shaman Pharmaceuticals Inc.
Item 1(b). Address of Issuer's Principal Executive Office:
213 East Grand Avenue
San Francisco, CA 94080
Item 2(a). Name of Person Filing: Weiss, Peck & Greer, L.L.C. ("WPG")
Item 2(b). Address of Principal Business Office, or if None, Residence:
One New York Plaza
New York, NY 10004
Item 2(c). Citizenship: WPG is a limited liability company, organized under the
laws of the State of Delaware
Item 2(d). Title of Class of Securities: Common Stock
Item 2(e). CUSIP Number: 819319500
Item 3. If this statement is Filed Pursuant to Rules 13d-1(b) or
13d-2(b), Check Whether the Person Filing is a:
(a) ( X ) Broker or Dealer registered under Section 15 of the
Securities Exchange Act of 1934 (the "Act")
(b) ( ) Bank as defined in Section 3(a) (6) of the Act
(c) ( ) Insurance Company as defined in Section 3(a) (19) of
the Act
(d) ( ) Investment Company registered under Section 8 of the
Investment Company Act of 1940
(e) ( X ) Investment Adviser registered under Section 203 of the
Investment Advisers Act of 1940
(f) ( ) Employee Benefit Plan which is subject to the
provisions of the Employee Retirement Income Security
Act of 1974 or Endowment Fund; see Sec. 240.13d-1(b)
(1) (ii) (F)
(g) ( ) Parent Holding Company, in accordance with Sec.
240.13d-1(b) (ii) (G) (Note: See Item 7)
(h) ( ) A savings associations as defined in Section 3(b) of
the Federal Deposit Insurance Act (12 U.S.C. 1813)
(i) ( ) A church plan that is excluded from the definition of
an investment company under Section 3(c)(14) of the
Investment Company Act of 1940 (15 U.S.C. 80a-3)
(j) ( ) Group, in accordance with paragraph 240.13d-1(b) (1)
(ii) (H)
<PAGE>
Cusip No. 819319500 Page 4 of 5
Item 4. Ownership:
(a) Amount Beneficially Owned: 190,000 as of December 31, 1999.
(b) Percent of Class: 5.71%
(c) Number of shares as to which such person has:
(i) sole power to vote: -0-
(ii) shared power to vote or to direct the vote: 190,000
(iii) sole power to dispose or to direct the
disposition of: -0-
(iv) shared power to dispose or to direct the
disposition of: 190,000
Item 5. Ownership of Five Percent or Less of a Class:
Not applicable.
Item 6. Ownership of More Than Five Percent on Behalf of Another Person:
This Statement on Schedule 13G ("Schedule 13G") is filed by WPG, a Delaware
limited liability company which is registered as a broker-dealer under Section
15 of the Act, and as an investment adviser under Section 203 of the Investment
Advisers Act of 1940, as amended.
This Schedule 13G is being filed with respect to 190,000 shares of common stock
of Shaman Pharmaceuticals Inc. (the "Common Stock") held by WPG at December 31,
1999 for the discretionary accounts of certain clients. By reason of Rule 13d-3
under the Act, WPG may be deemed to be a "beneficial owner" of such Common
Stock. WPG expressly disclaims beneficial ownership of the Common Stock. Each
client has the right to receive or the power to direct the receipt of dividends
from, or the proceeds from the sale of, such Common Stock purchased for his
account. To the knowledge of WPG, no person has the right to receive or the
power to direct the receipt of dividends from, or the proceeds from the sale of,
such Common Stock which represents more than 5% of the outstanding shares of the
Common Stock referred to in Item 4(b) hereof.
This Schedule 13G is not being filed with respect to the shares of Common Stock
which may be owned by managing directors of WPG, or by their respective spouses,
or as custodian or trustee for their respective family members or by their
respective family foundations, since WPG does not possess or share voting or
investment power with respect to such Common Stock. Each of such managing
director disclaims, pursuant to Rule 13d-4, that he or she is the beneficial
owner, within the meaning of Rule 13d-3, of the shares of Common Stock owned by
the various parties referred to in this Schedule 13G, other than such shares as
the respective managing director owns of record.
Item 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on By the Parent Holding Company:
Not applicable.
<PAGE>
Cusip No. 819319500 Page 5 of 5
Item 8. Identification and Classification of Members of the Group:
Not applicable.
Item 9. Notice of Dissolution of the Group:
Not applicable.
Item 10. Certification:
By signing below, I certify that, to the best of my knowledge and belief, the
securities referred to above as being held or owned beneficially by WPG were
acquired and are held in the ordinary course of business and were not acquired
and are not held for the purpose of or with the effect of changing or
influencing the control of the issuer of the securities and were not acquired
and are not held in connection with or as a participant in any transaction
having such purpose or effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
Dated: February 10, 2000
WEISS, PECK & GREER, L.L.C.
By: /s/ Michael E. Singer
--------------------------------
Michael E. Singer
General Counsel
Attention: Intentional misstatements or omissions of fact constitute
Federal criminal violations (see 18 U.S.C. 1001).
